3.18
price down icon29.96%   -1.36
after-market Dopo l'orario di chiusura: 3.15 -0.03 -0.94%
loading
Precedente Chiudi:
$4.54
Aprire:
$3.6
Volume 24 ore:
310.51K
Relative Volume:
5.33
Capitalizzazione di mercato:
$36.44M
Reddito:
$10.96M
Utile/perdita netta:
$-7.02M
Rapporto P/E:
-4.9688
EPS:
-0.64
Flusso di cassa netto:
$-3.72M
1 W Prestazione:
+64.77%
1M Prestazione:
+43.57%
6M Prestazione:
-29.02%
1 anno Prestazione:
-42.18%
Intervallo 1D:
Value
$3.00
$3.855
Intervallo di 1 settimana:
Value
$1.93
$4.98
Portata 52W:
Value
$1.55
$5.61

Collplant Biotechnologies Ltd Stock (CLGN) Company Profile

Name
Nome
Collplant Biotechnologies Ltd
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
57
Name
Cinguettio
@CollplantBio
Name
Prossima data di guadagno
2025-03-26
Name
Ultimi documenti SEC
Name
CLGN's Discussions on Twitter

Confronta CLGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CLGN
Collplant Biotechnologies Ltd
3.18 22.11M 10.96M -7.02M -3.72M -0.64
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-02-17 Iniziato Alliance Global Partners Buy

Collplant Biotechnologies Ltd Borsa (CLGN) Ultime notizie

pulisher
09:59 AM

CollPlant Biotechnologies First Quarter 2025 Earnings: Misses Expectations - simplywall.st

09:59 AM
pulisher
May 30, 2025

Dow Edges Higher; Dell Shares Fall After Q1 Results - Benzinga

May 30, 2025
pulisher
May 30, 2025

CollPlant Biotechnologies Launches Share Offering; Stock Drops - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

CollPlant Biotechnologies (CLGN) Rating and Price Target Analysis | CLGN Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

CollPlant (CLGN) Announces $3.6M Direct Offering and Private Placement - GuruFocus

May 30, 2025
pulisher
May 30, 2025

CollPlant Biotechnologies shares slide after announces capital raise of $3.6M through registered direct offering - MSN

May 30, 2025
pulisher
May 30, 2025

CollPlant (CLGN) Announces New Share and Warrant Sale Agreement - GuruFocus

May 30, 2025
pulisher
May 30, 2025

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRE - GuruFocus

May 30, 2025
pulisher
May 30, 2025

CollPlant announces $3.6 million stock offering By Investing.com - Investing.com India

May 30, 2025
pulisher
May 30, 2025

CollPlant announces $3.6 million stock offering - Investing.com Australia

May 30, 2025
pulisher
May 30, 2025

CollPlant Raises $3.6M to Advance AbbVie Partnership and Breakthrough Regenerative Medicine Programs - Stock Titan

May 30, 2025
pulisher
May 29, 2025

CollPlant Biotechnologies (NASDAQ:CLGN) Price Target Lowered to $12.00 at D. Boral Capital - Defense World

May 29, 2025
pulisher
May 29, 2025

CollPlant Biotechnologies Reports Strong Q1 2025 Results - TipRanks

May 29, 2025
pulisher
May 28, 2025

Collplant Biotechnologies Ltd reports results for the quarter ended March 31Earnings Summary - TradingView

May 28, 2025
pulisher
May 28, 2025

CollPlant Biotechnologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

CollPlant Biotechnologies (CLGN) Analyst Ratings Update | CLGN S - GuruFocus

May 28, 2025
pulisher
May 28, 2025

CollPlant Biotechnologies (CLGN) Analyst Ratings Update | CLGN Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL R - GuruFocus

May 28, 2025
pulisher
May 28, 2025

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE | CLGN Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - PR Newswire

May 28, 2025
pulisher
May 28, 2025

CollPlant Biotechnologies (CLGN) Expected to Announce Quarterly Earnings on Wednesday - Defense World

May 28, 2025
pulisher
May 27, 2025

Earnings Preview: CollPlant Biotechnologies - Nasdaq

May 27, 2025
pulisher
May 27, 2025

Global Tissue Engineering Market Insights & Industry Outlook | - openPR.com

May 27, 2025
pulisher
May 22, 2025

When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Breakeven? - simplywall.st

May 22, 2025
pulisher
May 14, 2025

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINAN - GuruFocus

May 14, 2025
pulisher
May 14, 2025

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS - Financial Times

May 14, 2025
pulisher
May 09, 2025

Renaissance Technologies LLC Acquires New Stake in CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World

May 09, 2025
pulisher
May 08, 2025

Here's Why We're A Bit Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation - Yahoo Finance

May 08, 2025
pulisher
Apr 24, 2025

CLGNCollplant Biotechnologies Ltd Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Collplant stock hits 52-week low at $2.14 amid market challenges - Investing.com India

Apr 24, 2025
pulisher
Apr 23, 2025

Collplant stock hits 52-week low at $2.14 amid market challenges By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 15, 2025

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevan - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

FDA Animal Testing Phase-Out: How CollPlant's BioInk Tech Could Revolutionize Drug Safety Studies - Stock Titan

Apr 15, 2025
pulisher
Apr 03, 2025

Collplant stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Collplant stock hits 52-week low at $2.47 amid market challenges - Investing.com India

Apr 03, 2025
pulisher
Mar 30, 2025

CollPlant Biotechnologies’ (CLGN) Buy Rating Reaffirmed at D. Boral Capital - The AM Reporter

Mar 30, 2025
pulisher
Mar 29, 2025

D. Boral Capital Reaffirms “Buy” Rating for CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

Collplant plans clinical trials for dermal filler and advances regenerative implants - MSN

Mar 28, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies (CLGN) to Release Earnings on Thursday - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... - Yahoo

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highl - GuruFocus

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Decline in Short Interest - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - StreetInsider.com

Mar 27, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Collplant Biotechnologies Q4 2024 misses forecasts - Investing.com India

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Reports 2024 Financial Results - TipRanks

Mar 27, 2025
pulisher
Mar 26, 2025

CollPlant’s Earnings Call: Mixed Outlook Amid Innovations - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

SEC Form 20-F filed by CollPlant Biotechnologies Ltd - Quantisnow

Mar 26, 2025
pulisher
Mar 26, 2025

Collplant Biotechnologies Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 25, 2025

Collplant stock hits 52-week low at $2.9 amid market challenges - Investing.com Australia

Mar 25, 2025

Collplant Biotechnologies Ltd Azioni (CLGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Capitalizzazione:     |  Volume (24 ore):